To continue using this website, please tell us a
little about yourself:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here

Login

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
 
You are here: Factsheet
 

OMW Norway AXA Framlington Health

3 FE Trustnet

Underlying Fund

FE Crown Rating ( Underlying )

Fund Objective ( Underlying )

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies.

Fund Manager ( Underlying )

Mark Hargraves

Domicile

Sector

Currency

Primary Asset Class

Fund Size

GBP 2.04m as at 31-Jul-2015

Downloads ( Underlying )

Unit Name

OMW Norway AXA Framlington Health

Inc/Acc

Accumulating 

Citicode

AS85

Initial Charge

n/a

Unit Currency

NOK 

ISIN

GB0005025621 

Annual Charge

n/a

Bid

NOK 48.94

Offer

NOK 48.94

Change (Offer)

1.57 (3.31%)
28-Aug-2015

Unit LaunchDate

21-Sep-2000

Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund 10.09 -1.70 3.08 24.02 83.71 143.84
Sector 0.06 -4.66 -2.76 1.83 18.36 27.31

Discrete Performance (%)

  2014 2013 2012 2011 2010
Fund 26.80 32.40 11.27 2.88 15.04
Sector 5.16 10.14 6.76 -5.30 8.11

Asset Allocation ( Underlying )

breakdown chart
  Asset Class % of Fund
North American Equities 71.11
Europe ex UK Equities 15.28
UK Equities 7.14
Money Market 2.21
Japanese Equities 1.85
Global Emerging Market Equities 1.74
Asia Pacific ex Japan Equities 0.67

Regional Breakdown ( Underlying )

breakdown chart
  Region % of Fund
North America 71.11
Europe ex UK 15.28
UK 7.14
Cash 2.21
Japan 1.85
Emerging 1.74
Developed Asia Pacific ex Japan 0.67

Sector Breakdown ( Underlying )

breakdown chart
  Sector % of Fund
Pharmaceuticals 32.77
Biotechnology, Life Sciences Tools & Services 26.99
Managed Health Care, Health Care Services & Health Care Distributors 16.76
Health Care Equipment 12.47
Other 5.30
Health Care Facilities 3.50
Cash 2.21
 

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.

 
 
Sign up for email alerts
Stay upto date on the latest fund research from FE
 
subscribe Readers of this page also looked at:
alter Pru PruFund Growth Fund
alter L&G Distribution
alter Pru PruFund Cautious Fund
alter FL Managed
alter FL FP With Profits
 
 
 
 
Data provided by FE. Care has been taken to ensure that the information is correct, but FE neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.